Advisory Committee and Panel Meeting Two-way Communication

DRAFT

Advisory Committee Meeting Communication Survey

FDA is looking to identify ways to enhance the communication that occurs between FDA and the public at Advisory Committee meetings. We would appreciate your feedback based on the meeting you attended today.

Your participation/non-participation is completely voluntary and your responses will not have an affect on your eligibility for receipt of any FDA services. All respondent identification and information are confidential and will be anonymous unless otherwise indicated. In instances where respondent identity is needed (e.g., for follow-up of non-respondents), this information collection fully complies with all aspects of the Privacy Act.

1. What is your affiliation? (Circle one)

Industry

Trade Association

Advocacy Group

FDA Staff

Press

Clinical Practitioner

Patient

General Public

Other (please specify) ____________________

2. What was your primary reason for attending today’s meeting?

____________________________________________________________________________________________

3. Please indicate your level of agreement with each of the following statements. Feel free to elaborate on your response in the space provided.

1 – Strongly Disagree, 2 – Disagree, 3 – Neither Agree Nor Disagree, 4 – Agree, 5 – Strongly Agree

Communication Topic	Agreement (Circle One)						Comments
The meeting provided an opportunity for the public to communicate their perspectives to the FDA Advisory Committee members.	1	2	3	4	5	N/A
The meeting provided an opportunity for the FDA to communicate information to the public.	1	2	3	4	5	N/A
The meeting was announced with enough time for me to plan my attendance.	1	2	3	4	5	N/A
The meeting location was convenient.	1	2	3	4	5	N/A
The meeting time was convenient.	1	2	3	4	5	N/A
Providing materials online before the meeting was useful.	1	2	3	4	5	N/A
Providing materials during the meeting was useful.	1	2	3	4	5	N/A
The content of the materials provided was useful.	1	2	3	4	5	N/A
I could clearly hear all speakers during the meeting.	1	2	3	4	5	N/A

Additional questions are located on the back of this page.

4. How did you find out about today’s meeting? (Circle all that apply)

FDA Website	FDA listserv email	Federal Register	Trade Publication Title: ___________________
Social Media _______________	Advocacy group Title: _______________	Press/Media	Other (please specify) _____________________

5. Which additional channels of communication would you like to see used to announce future Advisory Committee meetings? (Circle all that apply)

FDA Website

Social Media (e.g. Twitter, Facebook, etc.)

Email (listserv)

Text message alerts (SMS)

Other (please specify) _____________________

6. Which of the following channels of communication would you like to see used to broadcast future Advisory Committee meetings? (Circle all that apply)

FDA Webcast

Presentations via webcam

Third-party video broadcast

Audio streaming (podcast)

Other (please specify) _____________________

7. Which of the following materials would be useful to you if they were available on the FDA website following the final day of the meeting? (Circle all that apply)

Meeting Summary (24 hours)

Webcast video (24 hours)

Meeting presentation slides (24 hours)

Transcripts (3 – 4 weeks)

Meeting minutes (1 – 3 months)

Other (please specify) _____________________

8. Was anything about the meeting especially helpful in facilitating communication between FDA and the public? Please explain.

_________

_________

9. Do you have any suggestions for improving communication before, during or after future Advisory Committee meetings?

__________

__________

__________

__________

Thank you for your time – we appreciate your feedback!

Page 2 of 2